Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05095896
What this trial is testing

The Serum Lipid Profiles in ITP: a Retrospective Study

Who this might be right for
Immune Thrombocytopenia
Ming Hou 457
Testing effectiveness (Phase 2)Study completedNCT00961064
What this trial is testing

A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromesThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 30
Not applicableUnknownNCT03324087
What this trial is testing

Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China

Who this might be right for
Immune Thrombocytopenia
Shandong University 1,000
Not applicableStudy completedNCT02891109
What this trial is testing

Regulatory B Cells and Chronic Immune Thrombocytopenia

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicRegulatory B Cells
University Hospital, Brest 36
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Large-scale testing (Phase 3)Looking for participantsNCT07059000
What this trial is testing

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Chronic Primary Immune Thrombocytopenia (ITP)
Kedrion S.p.A. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Not applicableStudy completedNCT06444477
What this trial is testing

Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer

Who this might be right for
Immune ThrombocytopeniaImmune Thrombocytopenic PurpuraNeoplasms+1 more
University Hospital, Bordeaux 33
Post-approval studies (Phase 4)Study completedNCT05583838
What this trial is testing

Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Who this might be right for
Previously Treated Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 157
Not applicableLooking for participantsNCT07068126
What this trial is testing

Management of Children With Persistent ITP, A Novel Approach

Who this might be right for
Persistent Immune Thrombocytopenia
Assiut University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660172
What this trial is testing

Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)UnknownNCT05446831
What this trial is testing

Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
ITPImmune Thrombocytopenia
Peking University People's Hospital 35
Not applicableUnknownNCT02821572
What this trial is testing

Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Centre Hospitalier Universitaire Dijon 70
Large-scale testing (Phase 3)UnknownNCT03443570
What this trial is testing

Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

Who this might be right for
Immune ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic
Shandong University 200
Not applicableStudy completedNCT01727999
What this trial is testing

Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics

Who this might be right for
Immune Thrombocytopenia
Stanford University 75
Testing effectiveness (Phase 2)UnknownNCT05634824
What this trial is testing

IVIg Plus Low Dose rhTPO for ITP in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy Related
Peking University People's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Large-scale testing (Phase 3)Study completedNCT04225156
What this trial is testing

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Who this might be right for
Primary Immune Thrombocytopenia
argenx 101
Large-scale testing (Phase 3)Study completedNCT03156452
What this trial is testing

Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate

Who this might be right for
Immune Thrombocytopenia
University Hospitals Bristol and Weston NHS Foundation Trust 123
Testing effectiveness (Phase 2)UnknownNCT05852847
What this trial is testing

Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 216
Next Page